about
Red blood cell Thomsen-Friedenreich antigen expression and galectin-3 plasma concentrations in Streptococcus pneumoniae-associated hemolytic uremic syndrome and hemolytic anemia.Severe hemolysis after plasma transfusion in a neonate with necrotizing enterocolitis, Clostridium perfringens infection, and red blood cell T-polyagglutination.Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death.Red blood cells for transfusion in patients with sepsis: respective roles of unit age and exposure to recipient plasma.Design of the DREPAGREFFE trial: A prospective controlled multicenter study evaluating the benefit of genoidentical hematopoietic stem cell transplantation over chronic transfusion in sickle cell anemia children detected to be at risk of stroke by tIncidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease.Clinical severity in adult warm autoimmune hemolytic anemia and its relationship to antibody specificity.Neuraminidase enhances in vitro expansion of human erythroid progenitors.Anti-HI can cause a severe delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease patients.The use of rituximab to prevent severe delayed haemolytic transfusion reaction in immunized patients with sickle cell disease.Anti-T haemolysins: the effects of sialic acid removal and 2-aminoethylisothiouronium bromide treatment of erythrocytes on immune lysis.IgA-mediated human autoimmune hemolytic anemia as a result of hemagglutination in the spleen, but independent of complement activation and FcαRI.Up-regulation of cdc2 protein during paclitaxel-induced apoptosisPhosphorylation and proteasome-dependent degradation of Bcl-2 in mitotic-arrested cells after microtubule damageComplement activation in sickle cell disease: Dependence on cell density, hemolysis and modulation by hydroxyurea therapy
P50
Q33419595-AE38A153-1A62-43C0-B17B-C6E01B3A24F6Q40160880-5E2DCDC3-E735-4AC5-93DD-572A7DD6FA9BQ46026479-7686BF62-9819-45D6-93FE-A3BDD84EF1E3Q46358119-7FC9EC58-D803-44ED-A6F1-2D0D00783D4EQ48149034-01CB2C48-DDC0-4522-A53A-F8D8E2A96118Q48326469-2133C71A-6D26-4387-B530-AA282039D778Q49916968-1748BF91-D27A-4309-9C0D-C79E7D255E6CQ50232296-87EFC8CC-9BAC-44DC-968A-C66DD2E50905Q50241611-692C56C7-D956-4B64-A3B4-3F96FABA4665Q50454968-38CBDA67-3388-4BF8-9712-00A4698F9E8CQ50553423-007EBE04-50ED-45E8-A62D-CA7C8397C3DAQ50569444-6BD65F24-560F-4760-911E-241D3D7AF94EQ74218192-969E06EA-5156-409B-9CA3-526FAF56ED3DQ78202716-9270397D-2507-4301-96DA-7C5B65572462Q92992202-62D26C84-9809-4D87-A492-3A330D869BCE
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Philippe Chadebech
@ast
Philippe Chadebech
@en
Philippe Chadebech
@es
Philippe Chadebech
@nl
type
label
Philippe Chadebech
@ast
Philippe Chadebech
@en
Philippe Chadebech
@es
Philippe Chadebech
@nl
prefLabel
Philippe Chadebech
@ast
Philippe Chadebech
@en
Philippe Chadebech
@es
Philippe Chadebech
@nl
P106
P1153
23988328100
P31
P496
0000-0003-0757-4309